Level Ventures

Quantum Source is a developer of advanced photonic quantum computing systems based in Rehovot, Israel. The company focuses on creating a scalable quantum architecture that can support millions of qubits, utilizing chip-based photon-atom gates for efficient communication between photonic and atomic qubits. This innovative approach aims to significantly reduce the complexity, footprint, power consumption, and costs associated with quantum computing. By providing versatile building blocks for large-scale quantum systems, Quantum Source is positioned to enable industries to tackle complex problems in areas such as drug and material development, finance, cybersecurity, medicine, and climate simulations. The company's efforts are geared towards making practical, fault-tolerant quantum computers a reality, potentially transforming various sectors.

Enveda Biosciences is a biotechnology company that employs artificial intelligence-powered tools to investigate and define molecules sourced from living organisms. Its primary objective is to build an exhaustive database of chemical biodiversity, thereby expediting the discovery of novel medicines. The company's innovative drug discovery platform integrates machine learning, metabolomics, and robotics to analyze natural samples for both chemical structure and biological activity, eliminating the need for isolating individual compounds or extensive experimentation. This enables healthcare industry clients to develop a wide range of new medications, from antibiotics to hypotensives.

Enveda Biosciences is a biotechnology company that employs artificial intelligence-powered tools to investigate and define molecules sourced from living organisms. Its primary objective is to build an exhaustive database of chemical biodiversity, thereby expediting the discovery of novel medicines. The company's innovative drug discovery platform integrates machine learning, metabolomics, and robotics to analyze natural samples for both chemical structure and biological activity, eliminating the need for isolating individual compounds or extensive experimentation. This enables healthcare industry clients to develop a wide range of new medications, from antibiotics to hypotensives.

Perceptive Automata, Inc. is a technology company specializing in machine learning and computer vision solutions aimed at predicting human behavior in the context of automated driving. Founded in 2014 and located in Somerville, Massachusetts, the company addresses the complex challenges associated with the safe deployment of highly automated and fully autonomous vehicles, particularly in urban settings. Its advanced AI inference models allow vehicles to anticipate the actions of pedestrians, cyclists, and other drivers, enhancing safety and enabling smoother navigation in human-dominated environments. By integrating its software into autonomous driving systems, Perceptive Automata facilitates a more natural driving experience, which is crucial for the acceptance of autonomous vehicles and robotaxi services. The company's team comprises experts from prestigious institutions such as Harvard, MIT, and Stanford, reflecting a strong foundation in neuroscience and artificial intelligence.

Artivest operates an online investment platform that connects individual investors and financial advisors with opportunities in private equity and hedge funds, which are typically accessible only to institutional investors. By leveraging technological, financial, and operational expertise, Artivest offers a seamless investment experience while ensuring high security through advanced encryption technology. This platform allows a broader audience to participate in top-quality investment opportunities, thus democratizing access to private investments and enhancing the scalability for fund managers.